Breathing gas could save lives in critical lung failure

NCT ID NCT07334873

Summary

This study is testing whether adding inhaled nitric oxide gas to standard treatment can help adults with severe Acute Respiratory Distress Syndrome (ARDS) survive and spend less time on breathing machines. Researchers will compare 536 patients who receive either the nitric oxide treatment or a placebo, along with standard care, to see if it reduces deaths within 28 days. The goal is to find a better way to control this life-threatening lung condition that often requires intensive care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS (MODERATE OR SEVERE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China

Conditions

Explore the condition pages connected to this study.